|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/05 | |
| A61K 31/19 | |||
| A61K 31/4015 | |||
| A61P 25/08 |
| (11) | Patento numeris | 2661263 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12700294.7 |
| Europos patento paraiškos padavimo data | 2012-01-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-11-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2012/050002 |
| Data | 2012-01-03 |
| (87) | Numeris | WO 2012/093255 |
| Data | 2012-07-12 |
| (30) | Numeris | Data | Šalis |
| 201100043 | 2011-01-04 | GB |
| (72) |
WHALLEY, Benjamin, GB
WILLIAMS, Claire, GB
STEPHENS, Gary, GB
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535,
JP
GW Pharma Limited, Sovereign House, Histon Cambridge CB24 9BZ, GB |
| (54) | USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY |
| USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY |